Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions
Condition(s):BioequivalenceLast Updated:August 11, 2020Completed
Hide Studies Not Open or Pending
Condition(s):BioequivalenceLast Updated:August 11, 2020Completed
Condition(s):BioequivalenceLast Updated:August 14, 2020Completed
Condition(s):BioequivalenceLast Updated:December 3, 2020Active, not recruiting
Condition(s):BioequivalenceLast Updated:August 11, 2020Completed
Condition(s):BioequivalenceLast Updated:November 30, 2020Completed
Condition(s):Ebola Virus SurvivorLast Updated:October 18, 2018Terminated
Condition(s):Ebola Virus DiseaseLast Updated:November 15, 2016Completed
Condition(s):Influenza, Human; Critical Illness; InfluenzaLast Updated:May 15, 2019Completed
Condition(s):Covid19Last Updated:September 22, 2020Recruiting
Condition(s):COVID19Last Updated:July 28, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.